Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs
Source :- Companies Read More
Tata-backed Impetis licenses JAK inhibitor assets to Vyome Holdings
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
